Affiliation:
1. City Clinical Hospital No. 1 named after N.I. Pirogov of the Department of Healthcare of the City of Moscow
2. City Clinical Hospital No. 40 of the Department of Healthcare of the City of Moscow; FSBE HE N.I. Pirogov RNRMU MOH Russia
3. FSBE HE N.I. Pirogov RNRMU MOH Russia
4. City Clinical Hospital No. 1 named after N.I. Pirogov of the Department of Healthcare of the City of Moscow; FSBE HE N.I. Pirogov RNRMU MOH Russia
5. Military Medical Academy named after S.M. Kirov
Abstract
Introduction. The prevalence of rhabdomyolysis among people admitted to the hospital due to acute poisoning reaches, according to various foreign sources, from 30 to 40%. In 60% of cases, the development of rhabdomyolysis in adult patients is associated with acute exogenous intoxication. Currently, data on the prevalence, structure and outcomes of treatment of rhabdomyolysis in toxicological patients are mainly presented by the results of foreign clinical and epidemiological studies. The aim is to study the prevalence, structure, frequency of complications and outcomes of treatment of rhabdomyolysis in acute exogenous intoxication in a multidisciplinary hospital. Material and methods. The study included 1,363 patients who were treated from 2017 to 2020 with acute exogenous intoxication. During the study, 98 patients with rhabdomyolysis were selected from the general group. The frequency of poisoning with various toxicants was analyzed, the effects of which led to the development of rhabdomyolysis in acute exogenous intoxication. The incidence of acute kidney injury (AKI) was detected, the outcomes of acute poisoning treatment, the duration of inpatient treatment were determined, and a comparative analysis was carried out between groups of patients with rhabdomyolysis in acute exogenous intoxication (n=98) and without it (n=1265). Results. The prevalence of rhabdomyolysis among patients hospitalized for acute poisoning was 7%. The main reason for the development of rhabdomyolysis was the use of narcotic drugs - 87% of cases. The development of rhabdomyolysis in acute exogenous intoxication in 59.2% of cases is accompanied by the occurrence of AKI, which is significantly higher than among patients without rhabdomyolysis (11.6%). The occurrence of rhabdomyolysis in toxicological patients increases hospital mortality from 6.1 to 10.2%, as well as the duration of inpatient treatment and intensive care by 5.2 and 3.3 days, respectively. Limitations. The study was conducted based on only one multidisciplinary hospital in Moscow in the period from 2017 to 2020. Conclusion. Rhabdomyolysis is a serious complication of acute poisoning, the development of which significantly worsens the outcomes of treatment of patients with a toxicological profile, which requires the development of effective methods for the prevention, diagnosis and treatment of rhabdomyolysis in acute exogenous intoxication.
Publisher
Federal Scientific Center for Hygiene F.F.Erisman
Reference7 articles.
1. Bel’skikh A.N., Zakharov M.V., Marukhov A.V., Korol’kov O.N. Comparison effectiveness of the of extracorporeal detoxification methods in the treatment of post-load rhabdomyolysis complicated by acute renal damage. Voenno-meditsinskiy zhurnal. 2019; 6(340): 49–54. (in Russian)
2. Michelsen J., Cordtz J., Liboriussen L., Behzadi, M., Ibsen M., Damholt M.B. et al. Prevention of rhabdomyolysis-induced acute kidney injury – A DASAIM/DSIT clinical practice guideline. Acta Anaesthesiol Scand. 2019; 63(5): 576–86. https://doi.org/10.1111/aas.13308
3. Ahmad S., Anees M., Elahi I., Fazal-E-Mateen. Rhabdomyolysis Leading to Acute Kidney Injury. J Coll Physicians Surg Pak. 2021; 31(2): 235–7. https://doi.org/10.29271/jcpsp.2021.02.235
4. Debelmas A., Benchetrit D., Galanaud D., Khonsari R.H. Case 251: Nontraumatic Drug-associated Rhabdomyolysis of Head and Neck Muscles. Radiology. 2018; 286(3): 1088–92. https://doi.org/10.1148/radiol.2018152594
5. Waldman W., Sein Anand J., Kabata P. The characteristics and outcomes of toxin-induced massive rhabdomyolysis. Int J Occup Med Environ Health. 2020; 33(5): 661–73. https://doi.org/10.13075/ijomeh.1896.01532